Xenon Pharmaceuticals Inc (XENE)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Xenon Pharmaceuticals Reports Strong Financial Results and Advances in Epilepsy Program
Xenon Pharmaceuticals to Unveil Exciting Neurology Breakthroughs at AES 2023 Conference
Xenon Pharmaceuticals Empowers Neurology Research with $225 Million Public Offering
Xenon Pharmaceuticals Inc. Reports Stable Revenue, Signaling Consistency in Recent Fiscal Year
Major Pharmaceutical Preparations Company Maintains Steady Revenue in Q1 2023 Effort
The Losses have enlarged further at XENE in the financial third quarter of 2022